Better4All Personalized Intervention Pilot Study

NCT ID: NCT07120802

Last Updated: 2025-08-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

490 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-01

Study Completion Date

2025-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The BETTER4U project (Preventing obesity through Biologically and bEhaviorally Tailored inTERventions for you) is funded by the European Union (EU) and involves an international consortium consisting of 28 partners across Europe, Israel, and Australia. The project started in November 2023 and will run until October 2027. The main aim of BETTER4U is to improve weight management through a tailor-made intervention, the "BETTER4ALL personalized intervention", using modern monitoring tools and artificial intelligence (AI), including machine learning (ML) practices.

In the context of the BETTER4U project, the present Pilot Study aims to a) evaluate the usability, feasibility and acceptability of the BETTER4U mobile application ("BETTER4U App") and Intervention Platform that will be used to monitor and collect data from participants in the BETTER4ALL personalized intervention (randomized controlled trial; RCT) and b) collect data to evaluate and improve the BETTER4U causal AI models for the prevention of weight gain, before deploying them at large scale, as well as test and identify the optimal ways of delivering the AI-based interventions to the participants. The study will be conducted in seven sites in Cyprus, France, Greece, Poland, Portugal, Spain, and Sweden.

The BETTER4All Pilot Study will be a longitudinal, correlational, observational study, including a total of n=490 participants, equally distributed among the seven sites (i.e. n=70 per site). Specifically, n=60 (± 3-5) "general population" participants (henceforth: "end-users" of the wearables and the BETTER4U App) and n=10 (± 3-5) healthcare or other types of providers (henceforth: potential "implementers" of the BETTER4U intervention) will constitute each site's sample.

The study will involve the following two components: a) the administration of the wearables (smartwatches) to the "end-users" and their registration to and training on the BETTER4U App, to be used for a total duration of three weeks (21 days). During this period, their lifestyle behaviours (i.e. "BETTER4U Core Behavioural Indicators - BCBIs", such as eating occasions, physical activity, sedentary time, sleep etc.) and "living environment indicators - LEIs"; (e.g. access to parks in your area, distance from your home to your work place etc.) will be recorded daily, either in an automated way via the wearables or self-reported by the end-users through the App; and b) the registration to and training on the BETTER4U Intervention Platform of the "implementers" for a total duration of one week (7 days), during which they will be asked to test the platform's functionalities using synthetic data. The implementers will also be provided with the wearables and the App (similarly to the end-users) for one week only to allow collection of additional data that will help verify the accuracy of the algorithms in the gathered data from the wearables/monitoring tools regarding BCBIs and LEIs.

Overall, the outcomes and the findings of the Pilot Study will be used to further refine, optimize, and adjust the tools for the BETTER4ALL RCT, according to the feedback received by both end-users' and implementers' perspectives.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The BETTER4All Pilot Study is a multicenter, longitudinal, observational study designed to assess the usability, feasibility, and acceptability of the BETTER4U App and BETTER4U Intervention Platform, both of which integrate real-time behavioral monitoring and artificial intelligence (AI)-driven decision support tools. Conducted in seven European countries (Cyprus, France, Greece, Poland, Portugal, Spain, and Sweden), the study includes approximately 490 adult participants split into two groups: (a) "end-users" from the general population, who will use wearable devices and the mobile App for 21 days, and (b) "implementers," healthcare professionals who will test the intervention platform for 7 days using synthetic and self-recorded data.

The BETTER4U system employs Bluetooth Low Energy (BLE) smartwatches for passive data collection, including accelerometer signals, heart rate variability, sleep structure, and geolocation data. Data from the wearables and smartphone sensors are processed using AI and machine learning algorithms to derive behavioral indicators such as physical activity, eating, sleep patterns (termed BETTER4U Core Behavioral Indicators - BCBIs), and contextual environmental factors (Living Environment Indicators - LEIs). These indicators are calculated both locally and on secure servers via structured data pipelines, ensuring privacy and GDPR compliance.

Data collection comprises three sources: (1) passively collected wearable/App data, (2) online questionnaires via RedCap (e.g., IPAQ, GAD-2, PHQ-2, EQ-5D-5L, PSQI, Mini-EAT), and (3) "ground truth" data logged by implementers to validate algorithmic outputs. Engagement metrics, such as app usage duration and feature interaction frequency, are also automatically recorded. Feedback on usability and feasibility is collected via validated tools, including the System Usability Scale (SUS), MAUQ, AIM, IAM, and FIM.

The primary technical aim is to verify and refine the causal AI models developed in earlier project phases (WP5), ensuring the system is optimized for personalized intervention delivery in the upcoming BETTER4ALL randomized controlled trial (WP7).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity Prevention

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Longitudinal, correlational, observational pilot study
Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

End-users - General Population Participants

Adults from the general population (aged 18- 65 years, with normal weight or overweight/obesity) who will use the BETTER4U mobile application and a wearable smartwatch for 21 days. During this period, lifestyle behaviors and living environment indicators will be recorded daily, either automatically via the wearable or through self-reports via the app.

Group Type OTHER

BETTER4U Mobile App and Wearable Use (End-User Group)

Intervention Type BEHAVIORAL

Participants from the general population ("end-users") will use a smartwatch and the BETTER4U mobile app for 21 days. The app passively collects data (physical activity, sleep, eating behaviors, environment), while participants may self-report certain behaviors. The goal is to assess the usability, feasibility, and acceptability of the tools and to collect real-world behavioral data for refining AI models.

Implementers - Healthcare Professionals

Healthcare professionals (e.g., medical doctors, dietitians/nutritionists, psychologists, nurses) who will use the BETTER4U Intervention Platform, mobile application, and wearable smartwatch for 7 days. During this period, they will interact daily with the Intervention Platform using synthetic data to evaluate its functionalities and usability. Additionally, they will wear the smartwatch and use the app to record lifestyle behavior and living environment indicators (LEIs). They will provide structured "growth truth" data (e.g., transportation mode, activity levels, sleep quality) to validate the accuracy of the AI algorithms. Their feedback will help optimize their intervention delivery system and AI-based tools before large-scale deployment.

Group Type OTHER

BETTER4U Intervention Platform Testing (Implementer Group)

Intervention Type BEHAVIORAL

Healthcare professionals and other potential implementers will test the BETTER4U Intervention Platform and mobile app for 7 days. They will assess system usability, complete synthetic case simulations, and provide daily feedback via Google Forms. They also wear the smartwatch and use the app for data validation purposes. The goal is to evaluate platform usability and collect ground-truth data for validating AI algorithm outputs.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

BETTER4U Mobile App and Wearable Use (End-User Group)

Participants from the general population ("end-users") will use a smartwatch and the BETTER4U mobile app for 21 days. The app passively collects data (physical activity, sleep, eating behaviors, environment), while participants may self-report certain behaviors. The goal is to assess the usability, feasibility, and acceptability of the tools and to collect real-world behavioral data for refining AI models.

Intervention Type BEHAVIORAL

BETTER4U Intervention Platform Testing (Implementer Group)

Healthcare professionals and other potential implementers will test the BETTER4U Intervention Platform and mobile app for 7 days. They will assess system usability, complete synthetic case simulations, and provide daily feedback via Google Forms. They also wear the smartwatch and use the app for data validation purposes. The goal is to evaluate platform usability and collect ground-truth data for validating AI algorithm outputs.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age: Participants aged 18-65 years to represent the adult general population.
* Body Mass Index (BMI):

* Overweight or obesity group: BMI ≥ 25 kg/m².
* Normal weight group: BMI 18.5-24.9 kg/m².
* Technology Use:

* Willingness and ability to use wearable devices and an Android mobile application for the duration of the study.
* Owning a smartphone device with the Android operating system.
* Eating utensil technique: dominant hand gestures that correspond to handling of food via a fork or a spoon.
* Language Proficiency: Ability to read and understand the language in which the mobile app and study materials are provided.
* Consent: Willing to provide informed consent to participate in the study.
* Residency: Must be a resident of one of the seven participating countries.
* Availability: Able to participate for the full three-week duration of the study and comply with the study protocol.

Exclusion Criteria

* Health Conditions: Pregnant or breastfeeding women, as they might have different lifestyle behaviours or health needs.
* Physical Limitations: Any physical or mental condition that would prevent the participant from using the wearable device or mobile application as intended.
* Eating utensil technique: eating food with chopsticks on a daily or regular basis.
* Technical Incompatibility: Individuals who do not own a compatible smartphone or are unable to use the provided wearable devices for technical reasons.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Navarra

OTHER

Sponsor Role collaborator

University of Cyprus

OTHER

Sponsor Role collaborator

Karolinska Institutet

OTHER

Sponsor Role collaborator

University SWPS

OTHER

Sponsor Role collaborator

UNIVERSITE LYON 1 CLAUDE BERNARD (UCBL)

UNKNOWN

Sponsor Role collaborator

CENTRO DE ESTUDOS E INVESTIGACAO EM DINAMICAS SOCIAIS E SAUDE ASSOCIACAO SEM FINS LUCRATIVOS (CEIDSS)

UNKNOWN

Sponsor Role collaborator

Harokopio University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yannis Manios

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yannis Manios, Professor

Role: PRINCIPAL_INVESTIGATOR

Department of Nutrition and Dietetics, School of Health Science & Education, Harokopio University, Athens, Greece

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Cyprus (Ucy)

Nicosia, , Cyprus

Site Status RECRUITING

Universite Lyon 1 Claude Bernard (Ucbl)

Villeurbanne, , France

Site Status RECRUITING

Harokopio University

Athens, Aticca, Greece

Site Status RECRUITING

Uniwersytet Swps (Swps)

Wroclaw, , Poland

Site Status RECRUITING

Centro de Estudos E Investigacao Em Dinamicas Sociais E Saude Associacao Sem Fins Lucrativos (Ceidss)

Lisbon, , Portugal

Site Status RECRUITING

Universidad de Navarra (Unav)

Pamplona, Navarre, Spain

Site Status RECRUITING

Karolinska Institutet

Huddinge, , Sweden

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Cyprus France Greece Poland Portugal Spain Sweden

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yannis Manios, Professor

Role: CONTACT

2109549156 ext. +30

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Constantinos Deltas, Professor

Role: primary

Julie-Anne Nazare

Role: primary

Yannis Manios, Professor

Role: primary

2109549156 ext. +30

Eva Karaglani

Role: backup

2109549340 ext. +30

Aleksandra L, Professor

Role: primary

Ana Isabel Rito, Professor

Role: primary

Mai Bes-Rastrollo, Professor

Role: primary

Ioannis Ioakeimidis

Role: primary

Related Links

Access external resources that provide additional context or updates about the study.

https://better4u.eu/

Better4U website link

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

B4U101080117

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

BfedBwell Optimization Pilot
NCT06184256 RECRUITING NA